Using clinical samples and in vitro and in vivo experiments, we also demonstrate that high expression of IL-1R8 in breast tumors modulates the expression of inflammatory mediators in the TME, affecting the mobilization and activation of immune cells and fostering tumor growth and metastasis. Here, SIGIRR is linked to neoplasm.